Zions Bancorporation, National Association’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.97M Sell
14,120
-8,485
-38% -$3.02M 0.32% 51
2025
Q4
$7.4M Sell
22,605
-2,561
-10% -$812K 0.34% 45
2025
Q3
$7.1M Sell
25,166
-10,088
-29% -$2.93M 0.35% 50
2025
Q2
$9.84M Buy
35,254
+3,740
+12% +$1.06M 0.53% 31
2025
Q1
$9.82M Buy
+31,514
New +$9.31M 0.62% 27

Other funds holding AMGN

Zions Bancorporation, National Association's AMGN Position: Q1 2026 in Review

Zions Bancorporation, National Association reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $3.02M and leaving 14,120 shares worth $4.97M. The position accounts for 0.32% of the portfolio, ranked #51.

Zions Bancorporation, National Association first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.84M in Q2 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Zions Bancorporation, National Association held 14,120 shares of Amgen worth $4.97M as of Q1 2026.
  • Zions Bancorporation, National Association sold 8,485 Amgen shares in Q1 2026, an estimated $3.02M.
  • Amgen made up 0.32% of Zions Bancorporation, National Association's portfolio in Q1 2026, its #51 holding.
  • Zions Bancorporation, National Association first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • Zions Bancorporation, National Association's Amgen position peaked at $9.84M in Q2 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.